Who is sponsoring NCT05291312?

NCT05291312 is sponsored by Assiut University.

What condition does NCT05291312 study?

NCT05291312 studies Adenoid Hypertrophy.

Is NCT05291312 still recruiting?

NCT05291312 is currently status unknown. Last updated 22 March 2022.

Last reviewed 2022-03-22 · How we verify

NCT05291312

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EACA VS CCA in Postoperative Evaluation of Middle Ear Pressure

Status unknown NA Last updated 22 March 2022

What this trial tests

NA trial testing Adenoidectomy with endoscopic assisted coblation (EACA) and Adenoidectomy with conventional curettage (CCA) in Adenoid Hypertrophy in 70 participants. Status unknown.

Timeline

1 May 2022

Primary endpoint
1 October 2024

1 December 2024

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	70
Start date	1 May 2022
Primary completion	1 October 2024
Estimated completion	1 December 2024

Drugs / interventions tested

Adenoidectomy with endoscopic assisted coblation (EACA) and Adenoidectomy with conventional curettage (CCA)

Conditions studied

Adenoid Hypertrophy — all drugs for Adenoid Hypertrophy →

Sponsor

Assiut University

Who can join

Adults 5 to 14, any sex, with Adenoid Hypertrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Is to evaluate the effect on Eustachian Tube (ET) and changes in middle ear pressure in early period after adenoidectomy by using Endoscopic Assisted Coblation Adenoidectomy (EACA) VS Conventional Curettage Adenoidectomy (CCA)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Adenoid Hypertrophy

Currently open trials in the same condition.

NCT07094581 — Evaluation of the Effect of Adenoid Hypertrophy on the Masseter Muscle in Children: A Comparative Ultrasonographic Study · recruiting
NCT06266429 — Metabolomic Profiling of Racial Disparity · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05291312 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 22 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05291312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing